Examkin

Question

Difficulty: HardPediatric Genetic and Metabolic Disorders

A 1515-month-old boy is brought to the emergency department via ambulance after experiencing a generalized tonic-clonic seizure. His parents report that he has had a low-grade fever, vomiting, and poor oral intake for the past 4848 hours. On physical examination, the child is lethargic, hypotonic, and pale. Hepatomegaly is noted on abdominal palpation. Point-of-care testing reveals a blood glucose level of 2828 mg/dL (1.51.5 mmol/L). A urinalysis is notably negative for ketones. A metabolic crisis secondary to a fatty acid oxidation defect (such as medium-chain acyl-CoA dehydrogenase deficiency) is suspected. Arrange the following steps in the most appropriate chronological sequence for the immediate management, diagnostic workup, and long-term care of this patient.

  1. 1Draw blood for a 'critical sample' (including acylcarnitine profile and free fatty acids) while establishing intravenous access.
  2. 2Administer a rapid intravenous bolus of 25%25\% dextrose (D25WD25W) followed by a continuous dextrose infusion.
  3. 3Initiate intravenous L-carnitine supplementation to conjugate and clear toxic metabolic intermediates.
  4. 4Implement a preventative emergency illness protocol emphasizing the strict avoidance of fasting.
  5. 5Order targeted molecular sequence analysis of the ACADM gene to confirm the specific diagnosis.

Answer

The correct sequence is to first draw the critical diagnostic sample, immediately administer intravenous dextrose, initiate L-carnitine therapy, implement long-term fasting avoidance, and finally obtain confirmatory genetic testing.
The optimal sequence prioritizes obtaining diagnostic biochemical evidence (the critical sample) during the acute stress state, immediately followed by life-saving correction of hypoglycemia. Once the patient is neurologically stabilized and euglycemic, acute metabolic detoxifying agents (carnitine) are initiated. Long-term management focuses on dietary modification (avoiding fasting), and definitive diagnosis is later secured via molecular genetics.

Step-by-Step Solution

1
Recognize the clinical syndrome of hypoketotic hypoglycemia.
The combination of severe hypoglycemia and absent ketones strongly suggests a fatty acid oxidation defect, such as MCAD deficiency.
Normally, hypoglycemia triggers lipolysis and ketogenesis to provide alternate fuel for the brain; a failure to produce ketones implies a defect in beta-oxidation.
2
Prioritize the timing of diagnostic laboratories.
The 'critical sample' is drawn immediately upon establishing intravenous access, prior to pushing dextrose.
Exogenous glucose administration stimulates insulin release and halts lipolysis. Drawing labs after giving glucose will yield falsely normalized free fatty acids and acylcarnitines, leading to a missed diagnosis.
3
Execute life-saving resuscitation.
An intravenous bolus of 25%25\% dextrose is administered immediately after blood is drawn.
Severe hypoglycemia can cause irreversible neuronal damage; restoring euglycemia is the primary physiological goal.
4
Sequence the remaining acute and chronic interventions.
L-carnitine is given to clear toxins acutely, followed by establishing a long-term fasting avoidance plan, and finally sending genetic tests.
Management logically flows from immediate symptom control to acute metabolic detoxification, followed by lifelong prevention strategies, and finally definitive molecular confirmation.

Key Concept

Diagnosis and sequential management of hypoketotic hypoglycemia in fatty acid oxidation defects
Estimated Time:2m 0s
Rate this question

Topics

Pediatric Genetic and Metabolic Disorders

More questions from this topic